Page 52 - Adherence News Today

Continuation rates are higher with the new, more effective drugs, but even among those patients, more than half discontinue within a year.

A patient-facing voice-based conversational artificial intelligence application helped patients with type 2 diabetes optimize their insulin doses.

The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease.

A broad overview of patient-support programs should be a first step in weighing whether these programs deliver value for patients in return for their cost to the health system, says a researcher.

Atrial fibrillation treated with left atrial appendage closure was associated with ischemic strokes that were less severe than those among similar patients treated with direct oral anticoagulation.

A carefully tailored program in which physicians talked with heart failure (HF) patients about the cost of their medications improved medication adherence.

The study was conducted at 28 sites in the United Kingdom and three in the Netherlands.

Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.

The RNA interference therapeutic targeting synthesis of angiotensinogen lowered BP in adults with mild to moderate hypertension for up to 6 months after one dose in the phase 2 KARDIA-1 study.

New research found that improving diet quality did not protect against breast cancer recurrence overall; however, a subset of women who made the greatest dietary changes did benefit.